ARLINGTON, Tenn.--(BUSINESS WIRE)--Jun. 15, 2009-- Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical device company, has entered into an agreement with the Orthopaedic Research and Education Foundation (OREF) to broaden its support for advancing care through education and training by underwriting an OREF foot and ankle fellowship grant for 2009-2010.
The agreement establishes OREF as the company’s grant-making organization in graduate medical education for the coming academic year. The agreement stipulates that all aspects of the application, review, and grant approval process will be independently conducted by OREF.
“Partnering with OREF to support graduate medical education in a completely transparent way upholds the Wright tradition of setting new standards,” said Gary D. Henley, President and CEO. “We are proud to further excellence in patient care by supporting excellence in training.”
“Wright and OREF have a long history of collaborating to advance orthopaedic care through education and research,” said William P. Cooney III, M.D., chair of the OREF board of trustees. “The additional support for a 2009-2010 foot and ankle fellowship is particularly appreciated as we look for new ways to maintain the rigor of training for orthopaedic surgeons while managing escalating costs and adhering to ethical business practices.”
Wright Medical Group, Inc. is a global orthopaedic medical device company specializing in the design, manufacture and marketing of reconstructive joint devices and biologics. The Company has been in business for more than 50 years and markets its products in over 60 countries worldwide. For more information about Wright, visit our website at www.wmt.com.
OREF is an independent, non-profit organization created in 1955 to seek and receive donations from individuals and industry to foster research and education in orthopaedics. OREF has made more than 3,300 grants totaling nearly $95 million to individuals and organizations. For more information, visit www.oref.org.
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements made in this press release, other than statements of historical fact, are forward-looking statements. Forward-looking statements reflect management's current knowledge, assumptions, beliefs, estimates, and expectations and express management's current views of future performance, results, and trends and may be identified by their use of terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” and other similar terms. The Company wishes to caution readers that actual results might differ materially from those described in the forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, including the factors discussed in the Company’s filings with the Securities and Exchange Commission (including the Company’s annual report on Form 10-K for the year ended December 31, 2008, under the heading, “Risk Factors”), which could cause the Company’s actual results to materially differ from those described in the forward-looking statements. Although the Company believes that the forward-looking statements are accurate, there can be no assurance that any forward-looking statement will prove to be accurate. A forward-looking statement should not be regarded as a representation by the Company that the results described therein will be achieved. The Company wishes to caution readers not to place undue reliance on any forward-looking statement. The forward-looking statements are made as of the date of this press release. The Company assumes no obligation to update any forward-looking statement after this date.
Source: Wright Medical Group, Inc.
Wright Medical Group, Inc.
John K. Bakewell, 901-867-4527